Regular use of Low Dose Aspirin reduces Myocardial Infarction, Acute Coronary Syndrome by 33% in men and 17% of strokes in women


 FAMILYCON Lahore celebrates Aspirin Day

Regular use of Low Dose Aspirin reduces
Myocardial Infarction, Acute Coronary Syndrome
by 33% in men and 17% of strokes in women

We must emphasize on prevention and modifiable risk factors to reduce
morbidity and mortality from cardiac diseases - Prof. Akbar Chaudhry

LAHORE: Pakistan is a poor country hence our major efforts in the health sector should be on prevention of cardiovascular diseases since curative services are extremely expensive. This is possible by intervention in the modifiable risk factors i.e. stop smoking, control diabetes, hypertension, lipids, weight and in addition prescribe low dose Aspirin for primary & secondary prevention unless contra indicated. This was stated by Prof. M. Akbar Chaudhry President of Pakistan Aspirin Foundation who is also Principal of Azra Naheed Medical College, Lahore. Hew was the guest speaker at Aspirin Day celebrated by Familycon, a group of family physicians here recently. It was very well attended by their members.

Prof. M. Akbar Chaudhry President Pakistan Aspirin Foundation speaking on Aspirin – a wonder drug at a meeting organized by Familycon for family physicians at Lahore recently. Picture also shows Dr.M. Sarwar Chaudhry participating in the discussion besides a view of the participants.

The theme of the lecture was “Aspirin: A Wonder Drug”. Prof. Chaudhry said that the real threat to the urban health is the cardiovascular diseases, which is more common in the urban areas as compared to rural areas. It is estimated that 17.1 million people died of CVD in 2004 representing 29% of all global deaths and by 2030 it is expected that 23.6 million people will die from heart disease and stroke annually. The major disease burden (82%) is in the low & middle income countries affecting the men and women equally.
Prof. Chaudhry presented data from many international studies with the clear benefits of Aspirin in the primary & secondary prevention of cardiovascular and cerebrovascular diseases. He heighted the fact that Aspirin in low doses 75 – 100mg as Primary prevention reduced the incidence of MI, ACS by 33% in men and 17% of strokes in women. He recommended that all healthy individuals over the age of 45 with 10 years global risk of 10% or more of developing CVS & Strokes should be prescribed Aspirin.
He also discussed the recommendations of US Prevention Services Task Force and American Heart Association and also spoke about the benefits of combination treatment of Aspirin & Clopidogrel. One must ensure that blood pressure is under control before these hypertensive patients are prescribed low dose Aspirin therapy, he remarked.
Prof. Akbar Chaudhry also highlighted the aims and objectives besides accomplishments of Pakistan Aspirin Foundation ever since its inception. It has a very democratic set up and all the former Presidents of the Foundation as well as founder members have played an important role in creating awareness about the use of Aspirin in its well established indications besides CME programmes organized all over the country on regular basis for the last many years.
The presentation was followed by lively discussion. Responding to various questions Prof. Akbar Chaudhry said that for cardiac patients, the recommended dose is 75-150mg daily and all are equally effective. For cerebro vascular diseases the recommended dose is 150 – 300mg. He also stressed that in case of Acute MI, ACS, Soluble Aspirin should be given to the patient immediately dissolved in water or sublingually and if given within six hours, is as effective as Streptokinase. Side-effects of Aspirin and recommendations to stop Aspirin before elective surgery were also discussed in detail. Enteric coated Aspirin, he said, is preferred because of its safety in long term use, he added
At the end Prof. Akbar Chaudhry paid special thanks and tribute to the management of Atco Laboratories who have been sponsoring all the Academic Activities of Pakistan Aspirin Foundation for the last 12 years. We are extremely grateful to them. However, keeping up the professional ethics, we do not patronize or recommend any particular brand of Aspirin and it is up to the treating physician to make a choice. He also commended the local Atco team for organizing such a useful academic activity for the family physicians in Lahore. The session was moderated by Dr. Farrukh Mahmood.